Improving Gastrointestinal Function In High-Risk Newborns By Stimulation Of The Enteric Nervous System
NeoHemoHapt
1 other identifier
interventional
200
1 country
1
Brief Summary
The goal of this therapeutical intervention trial is to investigate whether tactile-kinesthaetic and oral sensorimotor stimulation can improve gastrointestional function in preterm infants born before gestational age of 30 weeks and newborns with congenital diaphragmatic hernia. The main question it aims to answer is: • To determine whether HAPTOS- intervention (Handling Adapted to Postnatal age with Tactile-kinaesthetic and Oral sensorimotor Stimulation) in the particpants results in earlier attainment (postnatal days) of full enteral feeding and/or full oral feeding (post menstrual age) compared to standard care. Researchers will compare an intervention group receiving standard of care plus HAPTOS intervention to a group of patients receiving only current standard of care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2024
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 21, 2023
CompletedFirst Posted
Study publicly available on registry
September 28, 2023
CompletedStudy Start
First participant enrolled
June 10, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 31, 2028
August 27, 2024
June 1, 2024
2 years
June 21, 2023
August 23, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Number of days to achieve full enteral feeding
measuring the time from birth until enteral intake reaches 150ml/kg/d
60 days
Postmenstrual age at achievement of full oral feeding
Number of postmenstrual weeks until gastrointestinal tube is taken out
52 weeks
Secondary Outcomes (13)
First meconium passage
14 days
Duration of meconium passage
14 days
Use of laxatives
60 days
Gastrointestinal Motility
100 days
Vomiting
duration of hospitalization up to 15 months
- +8 more secondary outcomes
Study Arms (2)
Standard care
NO INTERVENTIONWill receive standard of care according to the institutional protocol and principles of developmental care which currently belongs to (inter-) national guidelines and is regarded as safe.
Standard care supplemented with HAPTOS intervention
EXPERIMENTALWill receive standard of care according to the principles of developmental care which currently belongs to (inter-) national guidelines plus HAPTOS intervention which includes: tactile/ kinaesthetic massage of the trunk and extremities twice daily and stimulation of oral function by providing perioral stimulation up to 4 times a day. Interventions will be continued until clinical improvement.
Interventions
Tactile-kinaesthetic and Oral sensorimotor Stimulation
Eligibility Criteria
You may qualify if:
- Preterm birth at gestational age \< 30 weeks or
- Diagnosis of Congenital Diaphragmatic Hernia
- Born at Amalia Children's Hospital or admitted 1rst day of life
- Written informed consent of both parents or representatives
You may not qualify if:
- Preterm infant born at gestational age ≥ 30 weeks
- Perinatal Asphyxia; (Apgar score at 5' \< 5 and first pH ≤ 7,0)
- Major congenital anomalies or birth defects other than congenital diaphragmatic hernia;
- Metabolic disease that necessitates a special diet other than human milk or formula feeding and or has a prognosis of impaired neurological development
- Parental refusal of participation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Radboud University Medical Centerlead
- Nutricia Researchcollaborator
Study Sites (1)
Radboud University Nijmegen Medical Centre
Nijmegen, 6500 HB, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Viola Christmann, MD, PhD
Radboud University Medical Center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 21, 2023
First Posted
September 28, 2023
Study Start
June 10, 2024
Primary Completion (Estimated)
May 31, 2026
Study Completion (Estimated)
May 31, 2028
Last Updated
August 27, 2024
Record last verified: 2024-06